SI2608789T1 - Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina - Google Patents

Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina

Info

Publication number
SI2608789T1
SI2608789T1 SI201131177A SI201131177A SI2608789T1 SI 2608789 T1 SI2608789 T1 SI 2608789T1 SI 201131177 A SI201131177 A SI 201131177A SI 201131177 A SI201131177 A SI 201131177A SI 2608789 T1 SI2608789 T1 SI 2608789T1
Authority
SI
Slovenia
Prior art keywords
phenylsulfanyl
piperazine
dimethyl
phenyl
therapeutic uses
Prior art date
Application number
SI201131177A
Other languages
English (en)
Inventor
Marianne Dragheim
Ioana Florea
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44532506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2608789(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of SI2608789T1 publication Critical patent/SI2608789T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201131177A 2010-08-23 2011-08-22 Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina SI2608789T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37588510P 2010-08-23 2010-08-23
DKPA201000739 2010-08-23
PCT/DK2011/050317 WO2012025123A1 (en) 2010-08-23 2011-08-22 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine
EP11749331.2A EP2608789B1 (en) 2010-08-23 2011-08-22 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Publications (1)

Publication Number Publication Date
SI2608789T1 true SI2608789T1 (sl) 2017-06-30

Family

ID=44532506

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131177A SI2608789T1 (sl) 2010-08-23 2011-08-22 Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina

Country Status (30)

Country Link
US (4) US20130184291A1 (sl)
EP (1) EP2608789B1 (sl)
JP (1) JP5902169B2 (sl)
KR (1) KR101816953B1 (sl)
CN (1) CN103068389A (sl)
AP (1) AP3583A (sl)
AR (1) AR082501A1 (sl)
AU (1) AU2011295465B8 (sl)
BR (2) BR122020025600A2 (sl)
CA (1) CA2807062C (sl)
CL (1) CL2013000492A1 (sl)
CO (1) CO6680652A2 (sl)
CY (1) CY1118886T1 (sl)
DK (1) DK2608789T3 (sl)
ES (1) ES2625142T3 (sl)
HR (1) HRP20170608T1 (sl)
HU (1) HUE034155T2 (sl)
IL (1) IL224371A (sl)
LT (1) LT2608789T (sl)
ME (1) ME02674B (sl)
MX (1) MX349724B (sl)
PL (1) PL2608789T3 (sl)
PT (1) PT2608789T (sl)
RS (1) RS55851B1 (sl)
RU (1) RU2564666C2 (sl)
SG (1) SG187649A1 (sl)
SI (1) SI2608789T1 (sl)
TW (1) TW201212918A (sl)
WO (1) WO2012025123A1 (sl)
ZA (1) ZA201301385B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9822086B2 (en) 2014-01-31 2017-11-21 Egis Gyogyszergyar Zrt. Process for the preparation of vortioxetine salts
CN104119298B (zh) * 2014-08-13 2016-08-24 北京蓝贝望生物医药科技股份有限公司 氢溴酸沃赛汀或氢溴酸沃替西汀
CN104119299B (zh) * 2014-08-13 2016-08-17 北京蓝贝望生物医药科技股份有限公司 沃赛汀或沃替西汀的氢溴酸盐
CN104610195B (zh) * 2015-01-30 2017-06-27 上虞京新药业有限公司 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途
SG11201810644TA (en) 2016-07-01 2018-12-28 H Lundbeck As Vortioxetine dosing regimes for fast onset of antidepressant effect

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0543584B1 (en) * 1991-11-18 1996-05-22 Lilly Industries Limited Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
US20080103179A1 (en) * 2006-10-27 2008-05-01 Tam Peter Y Combination Therapy
AU2002211367A1 (en) 2000-10-02 2002-04-15 Rohr, Inc. Apparatus, method and system for gas turbine engine noise reduction
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
RS52205B2 (sr) * 2006-06-16 2021-05-31 H Lundbeck A/S 1-[2-(2,4-dimetilfenilsulfanil)-fenil]piperazin kao jedinjenje sa kombinovanom aktivnošću ponovnog uzimanja serotonina, 5-ht3 i 5-ht1a, za tretman kognitivnih oštećenja
TW200848411A (en) 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW200932233A (en) * 2007-11-13 2009-08-01 Lundbeck & Co As H Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity

Also Published As

Publication number Publication date
US20130184291A1 (en) 2013-07-18
SG187649A1 (en) 2013-03-28
AR082501A1 (es) 2012-12-12
MX349724B (es) 2017-08-10
WO2012025123A1 (en) 2012-03-01
PL2608789T3 (pl) 2017-09-29
HRP20170608T1 (hr) 2017-07-28
MX2013001570A (es) 2013-03-21
IL224371A (en) 2016-07-31
US20190000836A1 (en) 2019-01-03
CL2013000492A1 (es) 2013-06-07
DK2608789T3 (en) 2017-05-15
AP2013006768A0 (en) 2012-03-31
AU2011295465A1 (en) 2013-02-07
ZA201301385B (en) 2014-04-30
PT2608789T (pt) 2017-05-26
AP3583A (en) 2016-02-09
CY1118886T1 (el) 2018-01-10
JP2013536206A (ja) 2013-09-19
KR20130097162A (ko) 2013-09-02
RS55851B1 (sr) 2017-08-31
RU2564666C2 (ru) 2015-10-10
US20210085674A1 (en) 2021-03-25
ES2625142T3 (es) 2017-07-18
EP2608789B1 (en) 2017-04-12
US20220370439A1 (en) 2022-11-24
BR122020025600A2 (pt) 2021-01-05
AU2011295465B2 (en) 2014-06-19
BR112013002194A2 (pt) 2016-05-31
CA2807062C (en) 2018-07-31
CO6680652A2 (es) 2013-05-31
LT2608789T (lt) 2017-05-25
ME02674B (me) 2017-06-20
CA2807062A1 (en) 2012-03-01
JP5902169B2 (ja) 2016-04-13
CN103068389A (zh) 2013-04-24
EP2608789A1 (en) 2013-07-03
KR101816953B1 (ko) 2018-01-09
AU2011295465B8 (en) 2014-07-10
TW201212918A (en) 2012-04-01
HUE034155T2 (en) 2018-01-29
RU2013112890A (ru) 2014-09-27

Similar Documents

Publication Publication Date Title
PL2398785T3 (pl) Oczyszczanie 1-[2-(2,4-dimetylpfenylosulfanylo)fenylo]piperazyny
IL242279A0 (en) Compounds of 3-chloro-3]-n-(pyrimidine-2-ylamino)phenyl]substituted propanamide and their salts
ZA201107731B (en) Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
PL2521450T3 (pl) Grzybobójcze związki heterocykliczne
PL3290414T3 (pl) Sposób otrzymywania n-[5-(3,5-difluorobenzylo)-1h-indazol-3-ilo]-4-(4-metylopiperazyn-1-ylo)-2-(tetrahydropiran-4-yloamino)benzamidu
IL225770A0 (en) Heterocyclic compounds
EP2635284A4 (en) Heterocyclic compounds and their use
PL2353403T3 (pl) Zastosowanie 1-(2,4-dihydroksy-fenylo)-3-(3-hydroksy-4-metoksy-fenylo)-propan-1-onu
SI2800746T1 (sl) Postopek za proizvodnjo 1-(2-(2,4-dimetil-fenilsulfanil)-fenil-piperizina
EP2575462A4 (en) Heterocyclic compounds and their use
EP2643000A4 (en) THERAPEUTIC PIPERAZINES
HK1187339A1 (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
PL2621903T3 (pl) Związki n-heteroarylu
IL223721A0 (en) Heterocyclic compounds, their preparation and their therapeutic application
SI2608789T1 (sl) Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina
IL213917A0 (en) Novel compounds for medical use as peptidase effectors
GB201019043D0 (en) Use of 2',5'-oligoadenylate derivative compounds
AU2012900131A0 (en) "Heterocyclic compounds"
GB201021416D0 (en) Novel heterocyclic compounds
GB201009514D0 (en) Novel heterocyclic compounds
GB201102024D0 (en) Novel heterocyclic compounds 3
GB201101821D0 (en) Novel heterocyclic compounds 1
GB201101822D0 (en) Novel heterocyclic compounds 2
GB201101823D0 (en) Novel heterocyclic compounds 4
GB201004479D0 (en) Therapeutic use of new compounds I